VISKOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Viskase Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$4.05−0.09 (-2.27%)
Close on Oct 19, 2026
- Market cap
- $58.04M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Viskase Holdings, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q2 20 | Q1 20 | Q4 19 | Q3 19 | Q2 19 | Q1 19 | Q4 18 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | $36.23M | $33.38M | – | $41.21M | $43.49M | – | – | – | – | – | – | – | 40.2% | -12.1% |
| EMEA | $34.33M | $33.90M | – | $34.12M | $30.02M | – | – | – | – | – | – | – | 38.1% | +0.6% |
| South America | $11.04M | $11.39M | – | $11.60M | $11.40M | – | – | – | – | – | – | – | 12.2% | -4.9% |
| Asia | $8.53M | $7.88M | – | $10.36M | $9.37M | – | – | – | – | – | – | – | 9.5% | -17.7% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q2 20 | Q1 20 | Q4 19 | Q3 19 | Q2 19 | Q1 19 | Q4 18 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMEA | $2.10M | $745.00K | – | -$1.01M | $2.33M | – | – | – | – | – | – | – | -307.5% |
| Asia | $106.00K | $639.00K | – | $872.00K | $594.00K | – | – | – | – | – | – | – | -87.8% |
| South America | -$293.00K | $87.00K | – | $208.00K | $271.00K | – | – | – | – | – | – | – | -240.9% |
| North America | -$3.93M | -$5.80M | – | -$2.71M | -$17.60M | – | – | – | – | – | – | – | +45.1% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q2 20 | Q1 20 | Q4 19 | Q3 19 | Q2 19 | Q1 19 | Q4 18 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nojax | $49.83M | $46.72M | – | $50.75M | $52.11M | – | – | – | – | – | – | – | 55.3% | -1.8% |
| Fibrous | $24.61M | $24.67M | – | $28.00M | $25.19M | – | – | – | – | – | – | – | 27.3% | -12.1% |
| Plastic | $10.82M | $10.76M | – | $12.46M | $12.38M | – | – | – | – | – | – | – | 12.0% | -13.2% |
| Traded Goods | $2.47M | $2.02M | – | $2.32M | $2.00M | – | – | – | – | – | – | – | 2.7% | +6.7% |
| Large | $2.17M | $1.63M | – | $1.96M | $2.54M | – | – | – | – | – | – | – | 2.4% | +10.8% |
| Other | $228.00K | $733.00K | – | $1.79M | -$29.00K | – | – | – | – | – | – | – | 0.3% | -87.3% |
| Royalty | – | – | – | – | – | $7.93K | $1.75K | $22.00K | $2.00K | $142.00K | -$51.00K | $94.00K | – | – |
By region
From the segment and revenue-disaggregation notes of Viskase's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.